drugset
drugset / Trial / NCT05383300

Intranasal Oxytocin in Antiosocial Personality Disorder and Psychopathy

NCT05383300 ↗

Completed 72 enrolled King's College London Father Flanagan's Boys' Home · collab
RandomizedCrossoverTriple-blindOther

Summary

A pharmacoimaging study of oxytcoin in antisocial personality disorder and psychopathy

Timeline

Start
2017-05-01
Primary completion
2020-03-01
Completion
2021-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 40 iu Intranasal

Indications

antisocial personality disorder